Background
==========

Disturbance in the balance between vascular smooth muscle cell (VSMC) proliferation and death is directly involved in diseases such as atherosclerosis and post-PTCA restenosis. Drugs that modulate such phenotypic alterations may be useful in the control of these and other clinical situations.

Aim
===

The present study analyzes the effect of the triterpenoid tormentic acid (TA, from the plant *Rubus sieboldii*), a DNA polymerase inhibitor with anti-inflammatory properties, on cultured VSMC.

Methods
=======

Subconfluent cultures of embryonic rat aortic VSMC (A7r5) were exposed to increasing concentrations of TA or vehicle (DMSO) for 24 h, in the absence or presence of 10% fetal bovine serum (FBS), and apoptosis rates were evaluated through chromatin morphology analysis following DNA staining with the fluorescent dye HOE33342. In a separate series of experiment, A7r5 cells were cultured in 10% FBS continuously incubated with TA or vehicle. Cells were electronically counted (Coulter counter) at 2-day intervals.

Results
=======

TA (30 μM) significantly increased apoptosis of A7r5 cells under serum deprivation conditions (DMSO: 9.6 ± 1.5% vs TA: 17.9 ± 1.5%, *n*= 9, *P*\< 0.001), while cells cultured in FBS were not affected by the drug (DMSO: 2.0 ± 0.4% vs TA: 2.8 ± 0.4%, *n*= 9, *P*= 0.187). A7r5 cell proliferation was significantly inhibited by TA from the 6^th^day of culture on (a 30% cell count reduction, *n*= 12, *P*\< 0.001), with the relative difference in cell number remaining stable through the 8^th^day (33% reduction, *n*= 6, *P*\< 0.001).

Conclusions
===========

Our data indicate that TA is a VSMC apoptosis inducer and proliferation inhibitor. The absence of a pro-apoptotic effect associated with an anti-mitotic action in the presence of serum suggests that TA may be useful in preventing proliferative vascular diseases without negatively affecting normal vasculature. *In vivo*models of vascular lesion are currently being employed in order to investigate this hypothesis.
